Liver cancer stem cell therapy

Drug Profile

Liver cancer stem cell therapy

Alternative Names: Hepatocellular carcinoma stem cell therapy - NeoStem Oncology; Tumor stem cell specific dendritic cell therapy - Cellular Biomedicine Group; Tumor stem cell specific dendritic cell vaccine - Cellular Biomedicine Group; Tumour stem cell specific dendritic cell therapy - Cellular Biomedicine Group; Tumour stem cell specific dendritic cell vaccine - Cellular Biomedicine Group

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Hoag Memorial Hospital Presbyterian
  • Developer Cellular Biomedicine Group
  • Class Cancer vaccines; Dendritic cell vaccines; Immunotherapies; Stem cell therapies
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Hepatocellular carcinoma

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for phase-I development in Hepatocellular carcinoma in China (SC, Injection)
  • 11 Sep 2014 NeoStem Oncology licenses patents covering methods for use of apoptotic cells to deliver antigen to dendritic cells from Rockefeller University
  • 29 May 2014 DC-TC immunotherapy licensed to Cellular Biomedicines in China
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top